These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


439 related items for PubMed ID: 16264208

  • 1. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.
    Blackman DJ, Choudhury RP, Banning AP, Channon KM.
    J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208
    [Abstract] [Full Text] [Related]

  • 2. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.
    Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese L, Cernigliaro C, Niccoli L, Bartorelli AL, Rubartelli P, Reifart N, Heyndrickx GR, Saunamäki K, Morice MC, Sgura FA, Di Mario C, Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts investigators.
    Circulation; 2003 Jul 08; 108(1):37-42. PubMed ID: 12821546
    [Abstract] [Full Text] [Related]

  • 3. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention.
    Popma JJ, Cox N, Hauptmann KE, Reifart N, Virmani R, Emira K, Murphy S, Gibson CM, Grube E.
    Catheter Cardiovasc Interv; 2002 Oct 08; 57(2):125-34. PubMed ID: 12357506
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
    Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE, Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators.
    Circulation; 2002 Mar 19; 105(11):1285-90. PubMed ID: 11901037
    [Abstract] [Full Text] [Related]

  • 5. Distal embolization during native vessel and vein graft coronary intervention with a vascular protection device: predictors of high-risk lesions.
    El-Jack SS, Suwatchai P, Stewart JT, Ruygrok PN, Ormiston JA, West T, Webster MW.
    J Interv Cardiol; 2007 Dec 19; 20(6):474-80. PubMed ID: 18042052
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up after percutaneous coronary intervention with polytetrafluoroethylene-covered Symbiot stents compared to bare metal stents, with and without FilterWire embolic protection, in diseased saphenous vein grafts.
    Bennett J, Dens J, Stammen F, Coussement P, Janssens L, Claeys M, Vrolix M, Sinnaeve P, Dubois C, Desmet W.
    Acta Cardiol; 2013 Feb 19; 68(1):1-9. PubMed ID: 23457903
    [Abstract] [Full Text] [Related]

  • 7. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial.
    Turco MA, Buchbinder M, Popma JJ, Weissman NJ, Mann T, Doucet S, Johnson WL, Greenberg JD, Leadley K, Russell ME.
    Catheter Cardiovasc Interv; 2006 Sep 19; 68(3):379-88. PubMed ID: 16892434
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous saphenous vein graft interventions with and without distal filter wire protection.
    Hofmann M, Störger H, Schwarz F, Schwarz CE, Reinemer H, Ruef J, Schöpf J, Haase J.
    J Interv Cardiol; 2005 Dec 19; 18(6):475-9. PubMed ID: 16336428
    [Abstract] [Full Text] [Related]

  • 9. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.
    Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C.
    J Am Coll Cardiol; 2007 Oct 09; 50(15):1442-9. PubMed ID: 17919563
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and economic outcomes of embolic complications and strategies for distal embolic protection during percutaneous coronary intervention in saphenous vein grafts.
    Senter SR, Nathan S, Gupta A, Klein LW.
    J Invasive Cardiol; 2006 Feb 09; 18(2):49-53. PubMed ID: 16446515
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.
    Abdel-Karim AR, Banerjee S, Brilakis ES.
    J Invasive Cardiol; 2010 Jun 09; 22(6):253-7. PubMed ID: 20516502
    [Abstract] [Full Text] [Related]

  • 18. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2423-31. PubMed ID: 17174178
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical experiences using the FilterWire EX for distal embolic protection during complex percutaneous coronary interventions.
    Lev E, Teplitsky I, Fuchs S, Shor N, Assali A, Kornowski R.
    Int J Cardiovasc Intervent; 2004 Dec 19; 6(1):28-32. PubMed ID: 15204170
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.